Efficacy and Safety of Mobile App–Based Metamemory Cognitive Training for Mild Cognitive Impairment: Multicenter Randomized Clinical Trial
JMIR mHealth and uHealth · 19.01.2026 · 14 · e73464
DOI: 10.2196/73464 ↗Kurz gefasst
Randomisierte kontrollierte Studie in der Zeitschrift JMIR mHealth and uHealth, online erschienen am 19.01.2026. Verfasst von Sunyoung Kang und 12 weiteren Autor:innen. Beteiligte Einrichtung: Department of Psychiatry & Institute of Behavioral Science in Medicine, Yonsei University College of Medicine, Seoul, Republic of Korea. Hauptthemen laut MEDLINE: Cognitive Dysfunction, Mobile Applications, Cognitive Behavioral Therapy. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 70 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.
Abstract (Originalsprache)
Background
Metamemory training (MMT) offers a potential nonpharmacological approach to enhance cognitive function in individuals with mild cognitive impairment (MCI). While digital cognitive training improves accessibility, the effectiveness of mobile app–based MMT has not been evaluated in a randomized clinical trial.
Objective
We aimed to evaluate the efficacy and safety of a mobile app–based MMT program, ET-101 (Cogthera), compared to a sham device control group in individuals with MCI.
Methods
This multicenter, randomized controlled trial enrolled participants with MCI, recruited from 7 medical centers, and randomly assigned them to the ET-101 or control group (1:1 ratio). The intervention lasted 12 weeks, with a 12-week follow-up. The ET-101 group received metamemory-based multimemory strategy training and real-time feedback. Assessments of cognition, the daily activities of living, and the quality of life were conducted at baseline, week 12, and week 24. The primary outcome was the proportion of participants who showed cognitive improvement as assessed by the Alzheimer’s Disease Assessment Scale-Cognitive Subscale (ADAS-Cog)-14 at weeks 12 and 24. Secondary outcomes included changes in the scores of scales assessing cognition, daily activities, and quality of life. Safety analysis assessed adverse events and their relation to digital therapeutics.
Results
In the full analysis set, 49 participants were included in the ET-101 group and 50 in the control group. At week 24, the proportion of responders who maintained or improved their ADAS-Cog-14 scores was significantly higher in the ET-101 group than in the control group (P=.002). Additionally, the ET-101 group showed a significant improvement in ADAS-Cog-14 scores at week 24 compared to baseline levels (estimates=–2.53; t265=–3.05; Bonferroni-adjusted P=.003). A subdomain analysis revealed significant improvements in the memory (estimates=–2.50; t264=–4.03; Bonferroni-adjusted P
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Psychiatry & Institute of Behavioral Science in Medicine, Yonsei University College of Medicine, Seoul, Republic of Korea.
- Interdisciplinary Program in Cognitive Science, Seoul National University, Seoul, Republic of Korea.
- Cogthera GmbH, Munich, Germany.
- Graduate School of Medical Science, Brain Korea 21 Project, Yonsei University College of Medicine, Seoul, Republic of Korea.
- Metabolism-Dementia Research Institute, Yonsei University College of Medicine, Seoul, Republic of Korea.
- Department of Psychiatry, Konkuk University Medical Center, Seoul, Republic of Korea.
ORCID-Profile: Sunyoung Kang, Jung-In Lim, Lukas Stenzel, Keun You Kim, Eosu Kim, Hong Jun Jeon, Doo-Heum Park, Hyun Kook Lim, YongSoo Shim, Jae-Won Jang, Yeshin Kim, Sanghoon Lee, Kee Hyung Park
Zitieren
APA
Kang, S., Lim, J. I., Stenzel, L., Kim, K. Y., Kim, E., Jeon, H. J., Park, D. H., Lim, H. K., Shim, Y., Jang, J. W., Kim, Y., Lee, S., & Park, K. H. (2026). Efficacy and Safety of Mobile App–Based Metamemory Cognitive Training for Mild Cognitive Impairment: Multicenter Randomized Clinical Trial. JMIR mHealth and uHealth, 14, e73464. https://doi.org/10.2196/73464
Vancouver
Kang S, Lim JI, Stenzel L, Kim KY, Kim E, Jeon HJ, et al. Efficacy and Safety of Mobile App–Based Metamemory Cognitive Training for Mild Cognitive Impairment: Multicenter Randomized Clinical Trial. JMIR mHealth and uHealth. 2026;14:e73464. doi:10.2196/73464
BibTeX
@article{Kang2026,
author = {Kang, Sunyoung and Lim, Jung-In and Stenzel, Lukas and Kim, Keun You and Kim, Eosu and Jeon, Hong Jun and Park, Doo-Heum and Lim, Hyun Kook and Shim, YongSoo and Jang, Jae-Won and Kim, Yeshin and Lee, Sanghoon and Park, Kee Hyung},
title = {Efficacy and Safety of Mobile App–Based Metamemory Cognitive Training for Mild Cognitive Impairment: Multicenter Randomized Clinical Trial},
journal = {JMIR mHealth and uHealth},
year = {2026},
volume = {14},
pages = {e73464},
doi = {10.2196/73464}
}
EUVIMED